1. Interstitial lung disease. (2018) Authors: Collard, Harold R; Richeldi, L Record Type: Book Extent: 1 online resource (203 pages), illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interstitial lung disease. (©2012) Other Names: Jr, King, Talmadge E; Collard, Harold R; Richeldi, L Record Type: Book Extent: 1 online resource (xiii, 197 pages), illustrations (some color) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. M29 Fvc decline over 1 year predicts mortality but not subsequent fvc decline in patients with ipf. (15th November 2017) Authors: Richeldi, L; Kolb, M; Azuma, A; Stansen, W; Quaresma, M; Stowasser, S; Crestani, B Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. M33 Long-term efficacy of nintedanib is maintained in patients with idiopathic pulmonary fibrosis (ipf) irrespective of dose: subgroup analysis of inpulsis-on. (15th November 2017) Authors: Crestani, B; Kolb, M; Wallaert, B; Quaresma, M; Stansen, W; Richeldi, L Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Management of CAP using a validated risk score. Issue 2 (28th January 2005) Authors: Richeldi, L; Guglielmo, M De; Fabbri, L M; Giovanardi, D; Marchetti, F; Larosa, M; Solfrini, V; Altini, M Journal: Thorax Issue: Volume 60:Issue 2(2005) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Next-generation interstitial lung disease. (2021) Editors: Collard, Harold R; Richeldi, L; Johannson, Kerri A Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Orphan lung diseases : a clinical guide to rare lung disease /: a clinical guide to rare lung disease. (2015) Editors: Cottin, Vincent; Cordier, J-F (Jean-Francois); Richeldi, L Record Type: Book Extent: 1 online resource (xx, 580 pages), color illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P279 Reduction In Disease Progression With Nintedanib In The Inpulsis™ Trials. (10th November 2014) Authors: Cottin, V; Taniguchi, H; Collard, HR; Richeldi, L; Stowasser, S; Tschoepe, I; Schlenker-Herceg, R; Raghu, G Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P8 Pooled analysis of data from the TOMORROW and INPULSIS® trials of nintedanib in IPF. (12th November 2015) Authors: Richeldi, L; Brown, KK; Cottin, V; Selman, M; Kimura, T; Stowasser, S Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P9 Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis – initial clinical experience in a UK cohort. (12th November 2015) Authors: Fletcher, SV; Jones, MG; Renzoni, E; Parfrey, H; Hoyles, R; Spinks, K; Kokosi, M; Kwok, A; Warburton, C; Titmuss, V; Maher, T; Chua, F; Wells, A; Richeldi, L; Spencer, LG Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗